VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NAUT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NAUTNautilus Biotechnology, Inc.
$1.79$227M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNAUTQuarterly Financials

Nautilus Biotechnology, Inc. (NAUT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Nautilus Biotechnology, Inc. (NAUT) quarterly income statement — complete revenue, gross profit & net income history

NAUT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold1.48M1.59M1.62M1.63M1.63M6.35M1.61M1.6M1.59M1.59M1.51M1.42M1.17M921K0829K806K263K277K300K
COGS % of Revenue--------------------
Gross Profit-1.48M-1.59M-1.62M-1.63M-1.63M-6.35M-1.61M-1.6M-1.59M-1.59M-1.51M-1.42M-1.17M-921K0-829K-806K-263K-277K-300K
Gross Margin %--------------------
Gross Profit Growth %9.17%75%-0.43%-2.25%-2.14%-299.56%-6.4%-12.46%-35.87%-72.64%--71.29%-45.29%-250.19%100%-176.33%--35.57%--
Operating Expenses16.12M13.84M13.85M15.46M17.22M13.63M17.49M19.19M20.02M18.41M17.56M17.6M16.89M15.38M15.82M14.64M15.22M16.55M14.29M10.4M
OpEx % of Revenue--------------------
Selling, General & Admin6.42M5.85M4.67M5.53M6.15M2.78M5.71M7.27M7.6M6.5M6.06M6.08M6.4M6.14M6.25M6.07M5.84M6.92M6.32M4.32M
SG&A % of Revenue--------------------
Research & Development9.71M10.92M9.18M9.94M11.07M10.85M11.77M11.92M12.41M11.91M11.5M11.51M10.49M9.24M9.57M8.57M9.38M9.63M7.97M6.08M
R&D % of Revenue--------------------
Other Operating Expenses0-1000K000000000000000000
Operating Income-16.12M-15.42M-15.47M-17.1M-18.84M-19.98M-19.1M-20.79M-21.61M-20M-19.07M-19.02M-18.06M-16.3M-15.82M-15.47M-16.02M-16.82M-14.57M-10.7M
Operating Margin %--------------------
Operating Income Growth %14.43%22.8%18.99%17.76%12.79%0.1%-0.13%-9.32%-19.64%-22.68%-20.58%-22.91%-12.72%3.04%-8.59%-44.64%-800.12%-216.09%-261.76%-214.62%
EBITDA-14.65M-13.84M-13.85M-15.46M-17.22M-13.63M-17.49M-19.19M-20.02M-18.41M-17.56M-17.6M-16.89M-15.38M-14.96M-14.64M-15.22M-16.55M-14.29M-10.4M
EBITDA Margin %--------------------
EBITDA Growth %14.93%-1.53%20.79%19.42%13.97%25.98%0.41%-9.07%-18.52%-19.68%-17.38%-20.17%-11%7.07%-4.68%-40.84%-760.14%-222.92%-315.19%-221.79%
D&A (Non-Cash Add-back)1.48M1.59M1.62M1.63M1.63M6.35M1.61M1.6M1.59M1.59M1.51M1.42M1.17M921K860K829K806K263K277K300K
EBIT-16.12M-13.78M-13.57M-15.03M-16.61M-17.59M-16.45M-18.01M-18.73M-17.02M-15.88M-15.81M-14.96M-13.41M-15.82M-14.69M-15.76M-16.69M-14.5M-10.71M
Net Interest Income1.44M1.65M1.9M2.08M2.23M2.43M2.67M2.8M2.88M3.03M3.2M3.22M3.1M2.89M1.89M776K264K0136K0
Interest Income1.44M1.65M1.9M2.08M2.23M2.43M2.67M2.8M2.88M3.03M3.2M3.22M3.1M2.89M1.89M776K264K0136K0
Interest Expense00000000000000000000
Other Income/Expense1.43M1.64M1.9M2.06M2.23M2.39M2.65M2.78M2.88M2.98M3.2M3.21M3.1M2.89M1.76M783K259K127K64K-16K
Pretax Income-14.7M-13.78M-13.57M-15.03M-16.61M-17.59M-16.45M-18.01M-18.73M-17.02M-15.88M-15.81M-14.96M-13.41M-14.06M-14.69M-15.76M-16.69M-14.5M-10.71M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-14.7M-13.78M-13.57M-15.03M-16.61M-17.59M-16.45M-18.01M-18.73M-17.02M-15.88M-15.81M-14.96M-13.41M-14.06M-14.69M-15.76M-16.69M-14.5M-10.71M
Net Margin %--------------------
Net Income Growth %11.53%21.67%17.46%16.53%11.3%-3.35%-3.58%-13.93%-25.16%-26.96%-12.91%-7.62%5.06%19.65%3.04%-37.11%-791.06%-211.83%-264.61%-219.31%
Net Income (Continuing)-14.7M-13.78M-13.57M-15.03M-16.61M-17.59M-16.45M-18.01M-18.73M-17.02M-15.88M-15.81M-14.96M-13.41M-14.06M-14.69M-15.76M-16.69M-14.5M-10.71M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.12-0.11-0.11-0.12-0.13-0.14-0.13-0.14-0.15-0.14-0.13-0.13-0.12-0.11-0.11-0.12-0.13-0.13-0.12-0.19
EPS Growth %7.69%21.43%15.38%14.29%13.33%0%0%-7.69%-25%-27.27%-18.18%-8.33%7.69%15.38%8.33%36.84%48%23.53%7.69%-58.33%
EPS (Basic)-0.12-0.11-0.11-0.12-0.13-0.14-0.13-0.14-0.15-0.14-0.13-0.13-0.12-0.11-0.11-0.12-0.13-0.13-0.12-0.19
Diluted Shares Outstanding126.63M126.26M126.22M126.17M124.92M125.8M125.45M125.32M125.14M124.98M124.93M124.6M124.59M124.79M124.65M124.49M124.42M124.23M124.11M55.07M
Basic Shares Outstanding126.63M126.26M126.22M126.17M124.92M125.8M125.45M125.32M125.14M124.98M124.93M124.6M124.59M124.79M124.65M124.49M124.42M124.23M124.11M55.07M
Dividend Payout Ratio--------------------